Clinical Trial Update: Evaluate the Effect of Saxagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes [Phase 4]

View source ↗

Summary

An update describing a Phase 4 clinical trial evaluating the effect of saxagliptin on gut microbiota in adults with newly diagnosed type 2 diabetes; current sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Saxagliptin (saxagliptin)

Snippet

Sponsor: Beijing Chao Yang Hospital | Conditions: Type 2 Diabetes, Obesity | Phase 4 | Status: UNKNOWN